Cancer cells must acquire multiple mutations to evade the many restraints that prevent uncontrolled proliferation. Normal cells are vigilant in maintaining genome integrity (i.e. preventing mutations), but one hallmark of cancer cells is a defect in such self-surveillance and hence genome instability. Checkpoint controls that govern entry into mitosis are essential for maintaining genome integrity during cell proliferation. The Wee1 family kinases that inhibit cdc25 are among the targets for these checkpoints in mammalian cells and in yeast, but the basis for their regulation remains unclear. In budding yeast, the wee1 relative Swe1p is employed by the morphogenesis checkpoint, responding to perturbations of the actin cytoskeleton. We have identified a novel pathway controlling Swe1p degradation, and one aim of this proposal is to understand how Swe1p is targeted for degradation during the normal cell cycle, and how this process is halted by the checkpoint. The upstream pathways whereby cells can monitor the organization of the actin cytoskeleton will also be investigated. Although the morphogenesis checkpoint has not yet been identified in cells other than yeast, appropriate responses of mammalian cells to geometrical and mechanical features of their microenvironment are thought to involve sensing of similar types of cytoskeletal information. The metastatic potential of cancer cells increases upon derangement of these pathways, and the proposed studies will therefore provide new insight into cancer progression, and may yield potential targets for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM053050-07
Application #
6386200
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Zatz, Marion M
Project Start
1995-08-01
Project End
2004-07-31
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
7
Fiscal Year
2001
Total Cost
$266,140
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
King, Kindra; Kang, Hui; Jin, Michelle et al. (2013) Feedback control of Swe1p degradation in the yeast morphogenesis checkpoint. Mol Biol Cell 24:914-22
Chen, Hsin; Kuo, Chun-Chen; Kang, Hui et al. (2012) Cdc42p regulation of the yeast formin Bni1p mediated by the effector Gic2p. Mol Biol Cell 23:3814-26
Howell, Audrey S; Lew, Daniel J (2012) Morphogenesis and the cell cycle. Genetics 190:51-77
Chen, Hsin; Howell, Audrey S; Robeson, Alex et al. (2011) Dynamics of septin ring and collar formation in Saccharomyces cerevisiae. Biol Chem 392:689-97
Lew, Daniel J; Rout, Michael P (2009) Cell structure and dynamics. Curr Opin Cell Biol 21:1-3
Crutchley, John; King, Kindra M; Keaton, Mignon A et al. (2009) Molecular dissection of the checkpoint kinase Hsl1p. Mol Biol Cell 20:1926-36
Keaton, Mignon A; Szkotnicki, Lee; Marquitz, Aron R et al. (2008) Nucleocytoplasmic trafficking of G2/M regulators in yeast. Mol Biol Cell 19:4006-18
Keaton, Mignon A; Bardes, Elaine S G; Marquitz, Aron R et al. (2007) Differential susceptibility of yeast S and M phase CDK complexes to inhibitory tyrosine phosphorylation. Curr Biol 17:1181-9
McNulty, John J; Lew, Daniel J (2005) Swe1p responds to cytoskeletal perturbation, not bud size, in S. cerevisiae. Curr Biol 15:2190-8
Harrison, Jacob C; Zyla, Trevin R; Bardes, Elaine S G et al. (2004) Stress-specific activation mechanisms for the ""cell integrity"" MAPK pathway. J Biol Chem 279:2616-22

Showing the most recent 10 out of 28 publications